Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network [PDF]
Different models to investigate the prognosis of peripheral T cell lymphoma not otherwise specified (PTCL-NOS) have been developed by means of retrospective analyses.
Massimo Federico +2 more
exaly +8 more sources
Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS [PDF]
Key Points Microenvironmental immune cell signatures stratify PTCL-NOS patients into clinically meaningful disease subtypes. Immune-checkpoint inhibitors represent potential therapeutic options for a PTCL-NOS patient subgroup.
Takeshi Sugio +2 more
exaly +5 more sources
Peripheral T-cell lymphomas (PTCLs) are heterogenous T-cell neoplasms often associated with epigenetic dysregulation. We investigated de novo DNA methyltransferase 3A (DNMT3A) mutations in common PTCL entities, including angioimmunoblastic T-cell ...
Herek TA +26 more
europepmc +5 more sources
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS [PDF]
Primary Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma (PTCL-EBV) is a poorly understood disease which shows features resembling extranodal NK/T-cell lymphoma (ENKTL) and is currently not recognized as a distinct entity but categorized as a ...
Cho Mar Myint Wai +34 more
doaj +2 more sources
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) [PDF]
Review on Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), with data on clinics, and the genes ...
Rigolin, GM +11 more
core +4 more sources
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
Abstract The treatment of common nodal peripheral T-cell lymphomas (PTCLs), including PTCL, not otherwise specified (PTCL, NOS), anaplastic large-cell lymphomas, and T-follicular helper lymphomas, is evolving.
Alison J Moskowitz +2 more
exaly +5 more sources
Galectin-1 (Gal-1) has been associated with adverse prognosis in several cancers including lymphoma entities with CD30 expression. However, Gal-1 expression has not been systematically assessed in peripheral T-cell lymphomas (PTCL).
Steiniche, Torben +21 more
core +6 more sources
Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. [PDF]
Peripheral T-cell lymphomas (PTCL) are generally less common and pursue a more aggressive clinical course than B-cell lymphomas, with the T-cell phenotype itself being a poor prognostic factor in adult non-Hodgkin lymphoma (NHL).
Christopher D O Cooper +6 more
doaj +3 more sources
Peripheral T-cell lymphoma (PTCL-NOS)
chłoniak z obwodowych komórek T, gdzie indziej niesklasyfikowany, stanowi ok. połowy wszystkich chłoniaków T-komórkowych. Praca prezentuje jego dominującą lokalizację węzłową oraz dość agresywny przebieg kliniczny.
Sułek, Kazimierz
core +2 more sources
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) [PDF]
Nodal peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) remains a diagnosis encompassing a heterogenous group of PTCL cases not fitting criteria for more homogeneous subtypes.
Francesco Maura +37 more
core +6 more sources

